Stay updated on Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Sign up to get notified when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.

Latest updates to the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page
- CheckyesterdayChange DetectedA banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference0.3%

- Check8 days agoChange DetectedThe footer’s ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check15 days agoChange DetectedThe website footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check29 days agoChange DetectedNew version entries were added to the study history with updates to Study Status and Contacts/Locations. An older version was removed, signaling ongoing maintenance of the trial record.SummaryDifference0.3%

- Check36 days agoChange DetectedThe footer now shows Revision: v3.7.0, replacing the previous v3.6.6, indicating a minor update to the record history interface.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page footer revision changed from v3.6.5 to v3.6.6, indicating a page version update. This updates the metadata shown at the bottom of the study record history page without altering study data.SummaryDifference0.0%

Stay in the know with updates to Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Niraparib Combo vs Abiraterone in Metastatic Prostate Clinical Trial page.